Labeler
Fresenius Kabi USA, LLC NDC Codes
Fresenius Kabi USA, LLC lists 714 finished drug products in the FDA NDC Directory under NDC labeler codes 63323, 65219, 76045.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tyenne, Rocuronium, Sodium chloride, Dextrose, Otulfi, ketamine hydrochloride, Sterile Water, Levetiracetam, Cyclophosphamide, Vitalipid N, Ustekinumab-Aauz, Sodium Bicarbonate, ephedrine sulfate, Bomyntra, Succinylcholine Chloride
- Active ingredients
- Tocilizumab, Ustekinumab, Rocuronium bromide, Sodium chloride, Dextrose monohydrate, Phytonadione, Ketamine hydrochloride, Water, Levetiracetam, Denosumab, Cyclophosphamide, Vitamin a palmitate
- NDC labeler codes
- 63323, 65219, 76045
- Strengths (from the 100 most recently listed products)
- Rocuronium bromide 10 mg/mL; Dextrose monohydrate 50 mg/mL; Tocilizumab 162 mg/.9mL; Water 1 mL/mL; Sodium chloride .9 g/100mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Ephedrine sulfate 5 mg/mL; Denosumab 70 mg/mL; Succinylcholine chloride dihydrate 20 mg/mL; Diphenhydramine hydrochloride 50 mg/mL; Amiodarone hydrochloride 50 mg/mL; Epinephrine 1 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Acyclovir sodium 50 mg/mL; Lorazepam 2 mg/mL; Gadobutrol 604.72 mg/mL; Desmopressin acetate 4 ug/mL; Vitamin a palmitate 230 [iU]/mL; Ergocalciferol 40 [iU]/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Solution, Concentrate, Kit, Injection, Powder, For solution, Emulsion, Injection, Emulsion, Injection, Powder, Lyophilized, For solution, Solution
- Routes
- Intravenous, Subcutaneous, Intramuscular, Irrigation, Oral, Epidural, Infiltration, Perineural, Intraocular
- Drug classes (FDA established)
- Osmotic Laxative, Interleukin-6 Receptor Antagonist, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Potassium Salt, Nondepolarizing Neuromuscular Blocker, General Anesthetic, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, RANK Ligand Inhibitor, Benzodiazepine, Provitamin D2 Compound, Vitamin A, Norepinephrine Releasing Agent, Depolarizing Neuromuscular Blocker, Histamine-1 Receptor Antagonist, Antiarrhythmic, Catecholamine, Phenothiazine, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Opioid Antagonist, Gadolinium-based Contrast Agent, Factor VIII Activator, Vasopressin Analog, alpha-1 Adrenergic Agonist, Vitamin C, Paramagnetic Contrast Agent, Lipoglycopeptide Antibacterial, Heparin Reversal Agent, beta-Adrenergic Blocker, Amide Local Anesthetic, Calcitonin, Antifibrinolytic Agent, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Proton Pump Inhibitor, Oxytocic, Corticosteroid, Anticholinergic
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 65219-812 | 65219-0812-02 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 65219-814 | 65219-0814-05 | — |
| Dextrose and Sodium Chloridedextrose monohydrate and sodium chloride | Dextrose monohydrate 5 g/100mL; Sodium chloride .3 g/100mL | Injection, SolutionIntravenous | 63323-867 | 63323-0867-1063323-0867-7463323-0867-75 | — |
| Dextrose and Sodium Chloridedextrose monohydrate and sodium chloride | Dextrose monohydrate 5 g/100mL; Sodium chloride .45 g/100mL | Injection, SolutionIntravenous | 63323-869 | 63323-0869-1063323-0869-7463323-0869-75 | — |
| Dextrose and Sodium Chloridedextrose monohydrate and sodium chloride | Dextrose monohydrate 5 g/100mL; Sodium chloride .9 g/100mL | Injection, SolutionIntravenous | 63323-870 | 63323-0870-1063323-0870-74 | — |
| Dextrose and Sodium Chloridedextrose monohydrate and sodium chloride | Dextrose monohydrate 5 g/100mL; Sodium chloride .225 g/100mL | Injection, SolutionIntravenous | 63323-873 | 63323-0873-1063323-0873-7463323-0873-75 | — |
| Fentanyl Citrate | Fentanyl citrate 50 ug/mL | Injection, SolutionIntramuscular, Intravenous | 63323-808 | 63323-0808-11 | — |
| Ketorolac Tromethamine | Ketorolac tromethamine 30 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-209 | 76045-0209-10 | — |
| Ampicillinampicillin sodium | Ampicillin sodium 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 65219-016 | 65219-0016-10 | — |
| Heparin Sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | 63323-519 | 63323-0519-1063323-0519-77 | — |
| Micafunginmicafungin sodium | Micafungin sodium 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-728 | 63323-0728-10 | — |
| Micafunginmicafungin sodium | Micafungin sodium 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-729 | 63323-0729-12 | — |
| Micafunginmicafungin sodium | Micafungin sodium 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-729 | 63323-0729-10 | — |
| Potassium Chloride in Lactated Ringers and Dextrosepotassium chloride, sodium chloride, calcium chloride, sodium lactate, and dextrose monohydrate | Potassium chloride 1.79 g/1000mL + 4 more ingredients | Injection, SolutionIntravenous | 65219-246 | 65219-0246-10 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-262 | 63323-0262-06 | — |
| Sodium Chloride | Sodium chloride 3 g/100mL | Injection, SolutionIntravenous | 63323-530 | 63323-0530-75 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-262 | 63323-0262-36 | — |
| Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | 65219-052 | 65219-0052-29 | — |
| Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | 65219-054 | 65219-0054-29 | — |
| Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | 65219-056 | 65219-0056-29 | — |
| Ampicillinampicillin sodium | Ampicillin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 65219-018 | 65219-0018-10 | — |
| Diprivanpropofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | 65219-800 | 65219-0800-10 | — |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-540 | 63323-0540-1363323-0540-1563323-0540-36 | — |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-542 | 63323-0542-1363323-0542-14 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/.5mL | Injection, SolutionIntravenous, Subcutaneous | 63323-543 | 63323-0543-13 | — |
| Heparin Sodium | Heparin sodium 20000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 63323-915 | 63323-0915-13 | — |
| Ampicillinampicillin sodium | Ampicillin sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 65219-020 | 65219-0020-23 | — |
| Ampicillinampicillin sodium | Ampicillin sodium 250 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 65219-014 | 65219-0014-10 | — |
| Ertapenemertapenem sodium | Ertapenem sodium 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-823 | 63323-0823-20 | — |
| Dicyclomine Hydrochloride | Dicyclomine hydrochloride 10 mg/mL | Injection, SolutionIntramuscular | 63323-842 | 63323-0842-02 | — |
| Glucagon | — | Kit | 63323-582 | 63323-0582-82 | — |
| Fosaprepitant | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-972 | 63323-0972-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | 63323-531 | 63323-0531-90 | — |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | 63323-531 | 63323-0531-98 | — |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | 63323-533 | 63323-0533-83 | — |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | 63323-533 | 63323-0533-93 | — |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | 63323-535 | 63323-0535-87 | — |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | 63323-535 | 63323-0535-98 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 63323-537 | 63323-0537-84 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 63323-537 | 63323-0537-94 | — |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | 63323-539 | 63323-0539-03 | — |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | 63323-539 | 63323-0539-13 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 63323-605 | 63323-0605-84 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 63323-605 | 63323-0605-94 | — |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | 63323-607 | 63323-0607-88 | — |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | 63323-607 | 63323-0607-98 | — |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | 63323-609 | 63323-0609-90 | — |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | 63323-609 | 63323-0609-98 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 63323-751 | 63323-0751-13 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 63323-751 | 63323-0751-0563323-0751-10 | — |
Fresenius Kabi USA, LLC: common questions
- What is Fresenius Kabi USA, LLC's NDC labeler code?
- 63323, 65219, 76045. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Fresenius Kabi USA, LLC?
- Med-Code's HCPCS directory matches J3357, J0897, J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.